ZEALAND PHARMA

What this means for you

This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

79413868

Mark type

Stylized text

Filed

29 Oct 2024

Abandoned

29 Sept 2025

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical purposes; synthetic peptides for pharmaceuticals purposes; pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans, such as pharmaceutical preparations for treating endocrine disorders, immunity disorders, nutritional and metabolic diseases, such as diabetes and obesity; pharmaceutical preparations for the treatment and prevention of hypoglycemia; hypoglycemic agents; medical preparations in the nature of a liquid solution for medical purposes for the treatment and prevention of hypoglycemia; pharmaceutical preparations for treating gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; pharmaceutical preparations altering the immune system, such as complement inhibitors; apparatus and instruments containing pharmaceutical preparations, substances and medicines; medical rescue injection pens containing glucagon to treat severe cases of low blood sugar; pre-filled syringes for medical purposes.
• Class 009 — Scientific and electric apparatus: Computer software, including application software for smartphones [mobile phones], for tablet computers and other handheld or portable personal computers and for personal computers, all for determining treatment recommendations, dose calculation and patient support programs in the nature of providing medical information; databases and software, including application software and databases for use in connection with medical diagnosing, treatment, treatment planning and patient support programs; downloadable software configured for insulin monitoring and tracking blood glucose levels; downloadable software configured for the collection, editing, organizing, modifying, book marking, transmission, storage, sharing and analysis of data and information in the field of diabetes management; wearable devices for insulin monitoring; computer hardware and software for use with medical injection devices for collecting, transmitting and displaying medical data; medical software for the management of diabetes, obesity or gastrointestinal diseases; electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity and gastrointestinal diseases.
• Class 010 — Medical apparatus: Instruments and apparatus for administering pharmaceuticals; medical devices, namely, diabetes management devices, infusion and injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices and sensors used to continuously monitor the concentration of glucose in the human body; glucose monitors; glucose monitor accessories, namely, transmitters, receivers, and medical sensor insertion devices; wearable medical devices for insulin monitoring; infusion pumps for improvement of glycemic control and auto-injector pens for the treatment of hypoglycemia; medical rescue injection pens for administrating glucagon; parts and accessories for all the aforesaid goods.
• Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid; providing scientific information on diabetes, obesity and gastrointestinal diseases; hosting of websites and mobile apps in relation to technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity and gastrointestinal diseases; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity and gastrointestinal diseases; clinical trials.
• Class 044 — Medical, beauty and agricultural services: Medical services; medical analysis services for the diagnosis and treatment of humans; medical consulting services in the field of diseases, illnesses and ailments in humans; medical services related to the testing and treatment of patients with diabetes or low blood sugar (hypoglycemia); medical services related to testing and treatment of patients with gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; medical consulting services, namely, providing patient adherence programs to patients suffering from diabetes, obesity or gastrointestinal diseases; providing medical information via a website that provide a patient adherence program to patients suffering from diabetes, obesity or gastrointestinal diseases; medical information services, namely, providing information relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical advisory services, namely providing advisory services relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical services in the nature of patient support relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical information and advice in relation to treatment planning, including information and advice provided via the Internet, databases and application software; consultancy services relating to the aforesaid.

Owner

• ZEALAND PHARMA A/S, XP

Prosecution history

• 10 Oct 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
• 10 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 12 Apr 2025 — REFUSAL PROCESSED BY IB
• 27 Mar 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 27 Mar 2025 — REFUSAL PROCESSED BY MPU
• 19 Feb 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 19 Feb 2025 — NON-FINAL ACTION WRITTEN
• 19 Feb 2025 — ASSIGNED TO EXAMINER
• 07 Jan 2025 — APPLICATION FILING RECEIPT MAILED
• 07 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 02 Jan 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB